141 related articles for article (PubMed ID: 19619122)
61. Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS).
Ghaderi R; Artursson P; Carlfors J
Pharm Res; 1999 May; 16(5):676-81. PubMed ID: 10350010
[TBL] [Abstract][Full Text] [Related]
62. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
[TBL] [Abstract][Full Text] [Related]
63. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration.
Widmer MS; Gupta PK; Lu L; Meszlenyi RK; Evans GR; Brandt K; Savel T; Gurlek A; Patrick CW; Mikos AG
Biomaterials; 1998 Nov; 19(21):1945-55. PubMed ID: 9863528
[TBL] [Abstract][Full Text] [Related]
64. Drug release behavior of poly (lactic-glycolic acid) grafting from sodium alginate (ALG-g-PLGA) prepared by direct polycondensation.
Shi G; Ding Y; Zhang X; Wu L; He F; Ni C
J Biomater Sci Polym Ed; 2015; 26(16):1152-62. PubMed ID: 26255582
[TBL] [Abstract][Full Text] [Related]
65. Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method.
Nah JW; Paek YW; Jeong YI; Kim DW; Cho CS; Kim SH; Kim MY
Arch Pharm Res; 1998 Aug; 21(4):418-22. PubMed ID: 9875469
[TBL] [Abstract][Full Text] [Related]
66. Polymer based microspheres of aceclofenac as sustained release parenterals for prolonged anti-inflammatory effect.
Kaur M; Sharma S; Sinha VR
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():492-500. PubMed ID: 28024613
[TBL] [Abstract][Full Text] [Related]
67. Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters.
Katti DS; Robinson KW; Ko FK; Laurencin CT
J Biomed Mater Res B Appl Biomater; 2004 Aug; 70(2):286-96. PubMed ID: 15264311
[TBL] [Abstract][Full Text] [Related]
68. Preparation and evaluations in vitro of oxaliplatin polylactic acid nanoparticles.
Cui Z; Sun Y; Liu X; Ju F; Chen Q; Gao W; Wei H
Artif Cells Nanomed Biotechnol; 2013 Aug; 41(4):227-31. PubMed ID: 23305166
[TBL] [Abstract][Full Text] [Related]
69. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
70. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.
Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS
J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215
[TBL] [Abstract][Full Text] [Related]
71. Purification of Drug Loaded PLGA Nanoparticles Prepared by Emulsification Solvent Evaporation Using Stirred Cell Ultrafiltration Technique.
Paswan SK; Saini TR
Pharm Res; 2017 Dec; 34(12):2779-2786. PubMed ID: 28924739
[TBL] [Abstract][Full Text] [Related]
72. Next Generation Precision-Polyesters Enabling Optimization of Ligand-Receptor Stoichiometry for Modular Drug Delivery.
Ganugula R; Arora M; Saini P; Guada M; Kumar MNVR
J Am Chem Soc; 2017 May; 139(21):7203-7216. PubMed ID: 28395139
[TBL] [Abstract][Full Text] [Related]
73. [Preparation and quality evaluation of comet-shaped hydroxy camptothecin-loaded amphiphilic block copolymer].
Xie LY; Chang D; Hou ZQ; Yang XR; Han D
Yao Xue Xue Bao; 2016 Aug; 51(8):1309-15. PubMed ID: 29906035
[TBL] [Abstract][Full Text] [Related]
74. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
75. Single and multi-layered nanofibers for rapid and controlled drug delivery.
Fathi-Azarbayjani A; Chan SY
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):143-6. PubMed ID: 20118570
[TBL] [Abstract][Full Text] [Related]
76. Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.
Park J; Kadasala NR; Abouelmagd SA; Castanares MA; Collins DS; Wei A; Yeo Y
Biomaterials; 2016 Sep; 101():285-95. PubMed ID: 27310916
[TBL] [Abstract][Full Text] [Related]
77. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
Nandakumar V; Geetha V; Chittaranjan S; Doble M
Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
[TBL] [Abstract][Full Text] [Related]
78. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE
J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568
[TBL] [Abstract][Full Text] [Related]
79. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
[TBL] [Abstract][Full Text] [Related]
80. Development and structure of a novel barrier membrane composed of drug-loaded poly(lactic-co-glycolic acid) particles for guided bone regeneration.
Son JS; Kim SG; Jin SC; Piao ZG; Lee SY; Oh JS; Kim CS; Kim BH; Jeong MA
Biotechnol Lett; 2012 Apr; 34(4):779-87. PubMed ID: 22160329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
